| pubmed-article:7787140 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7787140 | lifeskim:mentions | umls-concept:C0221239 | lld:lifeskim |
| pubmed-article:7787140 | lifeskim:mentions | umls-concept:C0278348 | lld:lifeskim |
| pubmed-article:7787140 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:7787140 | pubmed:dateCreated | 1995-7-27 | lld:pubmed |
| pubmed-article:7787140 | pubmed:abstractText | Cytokines have been used in experimental and standard protocols for immune enhancement for cancer. The combination of interleukin-2 and interferon-alpha 2 beta has been used in experimental protocols for metastatic renal cell carcinoma. A man who developed rapidly progressive renal failure after receiving this combination therapy is reported. A renal biopsy revealed a pauci-immune crescentic glomerulonephritis. Antineutrophil cytoplasmic antibodies and antiglomerular basement membrane antibodies were absent. The spectrum of renal disease and potentially related extrarenal manifestations associated with interleukin-2 and inteferon-alpha are reviewed. A pathogenesis of altered cell-mediated immunity, consistent with abnormalities in extrarenal organs after immune enhancement, is proposed. | lld:pubmed |
| pubmed-article:7787140 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7787140 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7787140 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7787140 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7787140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7787140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7787140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7787140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7787140 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7787140 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:7787140 | pubmed:issn | 1046-6673 | lld:pubmed |
| pubmed-article:7787140 | pubmed:author | pubmed-author:ParkerM GMG | lld:pubmed |
| pubmed-article:7787140 | pubmed:author | pubmed-author:AtkinsM BMB | lld:pubmed |
| pubmed-article:7787140 | pubmed:author | pubmed-author:LeveyA SAS | lld:pubmed |
| pubmed-article:7787140 | pubmed:author | pubmed-author:UcciA AAA | lld:pubmed |
| pubmed-article:7787140 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7787140 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:7787140 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7787140 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7787140 | pubmed:pagination | 1740-4 | lld:pubmed |
| pubmed-article:7787140 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:7787140 | pubmed:meshHeading | pubmed-meshheading:7787140-... | lld:pubmed |
| pubmed-article:7787140 | pubmed:meshHeading | pubmed-meshheading:7787140-... | lld:pubmed |
| pubmed-article:7787140 | pubmed:meshHeading | pubmed-meshheading:7787140-... | lld:pubmed |
| pubmed-article:7787140 | pubmed:meshHeading | pubmed-meshheading:7787140-... | lld:pubmed |
| pubmed-article:7787140 | pubmed:meshHeading | pubmed-meshheading:7787140-... | lld:pubmed |
| pubmed-article:7787140 | pubmed:meshHeading | pubmed-meshheading:7787140-... | lld:pubmed |
| pubmed-article:7787140 | pubmed:meshHeading | pubmed-meshheading:7787140-... | lld:pubmed |
| pubmed-article:7787140 | pubmed:meshHeading | pubmed-meshheading:7787140-... | lld:pubmed |
| pubmed-article:7787140 | pubmed:meshHeading | pubmed-meshheading:7787140-... | lld:pubmed |
| pubmed-article:7787140 | pubmed:meshHeading | pubmed-meshheading:7787140-... | lld:pubmed |
| pubmed-article:7787140 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7787140 | pubmed:articleTitle | Rapidly progressive glomerulonephritis after immunotherapy for cancer. | lld:pubmed |
| pubmed-article:7787140 | pubmed:affiliation | Division of Nephrology, New England Medical Center, Boston, MA, USA. | lld:pubmed |
| pubmed-article:7787140 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7787140 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7787140 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:7787140 | pubmed:publicationType | Case Reports | lld:pubmed |
